CMS Should Account For Cost Of Blood Products, MedPAC Recommends
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Medicare & Medicaid Services should account for the cost of blood products when it next revises the hospital market basket index, the Medicare Payment Advisory Commission concluded at its Nov. 15 meeting in Washington, D.C